Thoracic aortic aneurysms are a life-threatening condition often diagnosed too late. To discover novel robust biomarkers, we aimed to better understand the molecular mechanisms underlying aneurysm formation. 
Introduction
Disorders of the heart and blood vessels, together known as cardiovascular disease (CVD), are a leading cause of death. Most often patients present with symptoms at a late and irreversible stage. A striking example is aneurysmal disease, of which the incidence increases with age. Aneurysms are large dilatations of the aorta that, when not detected in time, will result in aortic rupture associated with high mortality. This dilation of the aorta frequently occurs unnoticed up to a point where surgery is the only optional treatment left. Although most risk factors, such as lifestyle and age are known, the molecular mechanisms involved are often not yet fully understood. Without this knowledge, proper diagnosis and intervention treatments are difficult to implement.
The most important factors known to be involved to date are extracellular matrix (ECM) degeneration and alterations in the renin-angiotensin system (RAS) and transforming growth factor b (TGFb) signalling pathways. [1] [2] [3] [4] [5] [6] [7] [8] In fact, intervention strategies based on these targets are being explored. 9 Although some mitigating effects on degeneration and dilatation of the aorta have been observed, none of these treatments rescue the disease or reverse symptoms. [10] [11] [12] This must mean that still many processes and molecules involved need to be identified to complete the picture of how aneurysms are formed and progress.
To study the molecular mechanisms that underlie aneurysm formation, we developed a Fibulin-4 mouse model. [13] [14] [15] Fibulin-4 is a secreted glycoprotein, which is expressed in medial layers of blood vessels and is a critical component for the structural integrity and elasticity of the aortic wall. [16] [17] [18] Fibulin-4 protein levels in the aorta are essential for vascular maturation. The protein is located in microfibril bundles which tether elastic fibres to smooth muscle cells via integrin-mediated binding to regions of the cell membrane that are occupied by intracellular membrane-associated anchoring sites for actin filaments. 19 Insufficient levels of Fibulin-4 compromise the structural integrity of the aortic wall, which can lead to aneurysm formation. In agreement, patients with mutations in Fibulin-4 suffer from cardiovascular complications including aortic aneurysms, arterial tortuosity, and elastin abnormalities. [20] [21] [22] Fibulin-4 is an essential gene and complete deletion of this gene in the mouse leads to perinatal lethality. 23 However, in our Fibulin-4 R/R mouse model, Fibulin-4 is 4-fold reduced 13 , resulting in severe aortic aneurysms with associated aortic valve disease, thereby closely mimicking aneurysm formation of genetically affected patients. Notably, genome-wide aorta transcriptome and histological analyses of young R/R animals revealed TGFb signalling as one of the critical events in the pathogenesis of the observed aneurysm formation. 13 In this study, in order to identify additional underlying molecular mechanisms that may contribute to aneurysm formation, we performed proteomics, genomics, and functional experiments on aortas of adult Fibulin-4 R/R animals. Mostly, proteomics data reports on the absence or presence of certain proteins, whereas gene expression profiling data are subjected to pathway analysis. We hypothesized that by performing pathway analysis on our proteomics data, and by comparing gene and protein expression, this would hint us towards new important pathways that additionally play a role in aneurysm formation. Our omics data point to the fact that altered mitochondrial function and metabolism accompany aneurysm formation in Fibulin-4 R/R mice, which we substantiate with functional experiments. These findings offer new mechanistic insights into the complex disease of aneurysm formation.
Methods

Experimental animals
Fibulin-4 þ/R animals were bred into in a C57BL6 background to obtain Fibulin-4 R/R and wild-type mouse (Fibulin-4 þ/þ ) experimental animals (backcross 7). Fibulin-4 SMKO animals, with deletion of Fibulin-4 in VSMCs specifically, were kindly provided by Hiromi Yanigasawa 24 and bred into the same C57BL6 background. The numbers of animals used for each experiment are described in the Results section and mentioned in figures and/or figure legends. For each experiment with mutant animals, littermate controls were used unless stated otherwise. Animals were housed at the Animal Resource Centre (Erasmus University Medical Centre), which operates in compliance with the 'Animal Welfare Act' of the Dutch government, using the 'Guide for the Care and Use of Laboratory Animals' as its standard. As required by Dutch law, formal permission to generate and use genetically modified animals was obtained from the responsible local and national authorities. An independent Animal Ethics Committee consulted by Erasmus Medical Center (Stichting DEC Consult) approved these studies (permit number 140-12-05), in accordance with national and international guidelines. For the described experiments animals were sacrificed by CO 2 inhalation , unless stated otherwise. This study conforms to the guidelines from Directive 2010/63/EU of the European Parliament on the protection of animals used for scientific purposes or the NIH guidelines.
Preparation of aorta protein extracts and MS/MS protein identification
Fibulin-4 R/R and Fibulin-4 þ/þ littermate control mice (n = 2 per group, female) were sacrificed at an age of 80-90 days, and thoracic aortas were collected. Next, aorta protein extracts were made and protein concentration was determined as described. 25 Equal amounts of total protein were loaded and size separated on a gradient (5-20%) SDS gel. Subsequently, gels were stained with Coomassie Brilliant Blue. Lanes were excised from the gel and 5 mm slices were subjected to destaining, in-gel reduction with dithiothreitol, alkylation with chloroacetamide and digestion with trypsin (Promega, sequencing grade), essentially as described. 26 For Nanoflow LC-MS/MS details see Supplementary material online. The analysis was performed in duplicate on independent samples (n = 2 per genotype). Proteins with a Mascot score of 60 and higher with 
GO-term analysis
To classify proteins according to gene ontology (GO) terms, we used the AgBAse GOretriever for GO-term retrieval, which classifies proteins on the basis of cellular components (http://agbase.msstate.edu/cgibin/tools/goretriever_select.pl). For the 374 proteins that were identified as different between Fibulin-4 R/R and Fibulin-4 þ/þ , 342 could be assigned with a GO-term. These were separated into 12 categories: nucleus, cytoplasm, cytoskeleton, ECM, mitochondrion, proteasome, plasma membrane, ribosomes, endoplasmatic reticulum and sarcoplasmic reticulum (ER and SR), golgi and other (includes all other cellular components not mentioned before), and unknown. For each category, percentages were calculated by dividing proteins present in such category by all proteins assigned with a GO-term.
Microarray experiments
Total thoracic aorta RNA of 3-month old Fibulin-4 þ/þ (n = 3) and Fibulin-4 R/R (n = 2) was obtained using standard procedures (Qiagen). Images were taken with the IVIS Spectrum imaging system (Perkin Elmer). For molecular imaging, mice were sacrificed after an hour by an overdose of anaesthesia, and the chest was opened according to standard necropsy protocols. Data acquisition and analysis were performed using IVIS imaging software Living Image (Caliper). The photon flux was quantified within a region of interest encompassing the thoracic chest region of each mouse. The signal was normalized against an illumination profile for the selected field of view. Also see reference. 29 
DHE staining
Cryosections 10 lm thick were stored at -80 C. After thawing the sections, they were stained by 5 lM dihydroethidium (DHE) and 0.5 lg/mL Hoechst 33258 in phosphate buffered saline (PBS) for 30 min at 37 C in a humidified atmosphere. The fluorescence of the superoxide specific reaction product of DHE oxidation was measured using a fluorescence inverted microscope (Olympus IX50) equipped with a 460-490 nm band pass excitation filter and 515 nm emission IF-barrier filter, digitized with an F-view camera (Soft Imaging System, Münster, Germany), and analysed offline (AnalySIS 3.1; Soft Imaging System). To determine the integrated density ratio, we first determined the sum of the fluorescence values of the pixels in the ethidium (red) and 2-OH-ethidium (green) selection separately. Subsequently, the integrated intensity ratio was determined by dividing the 2-OH-ethidium (green) values over the ethidium (red) values for the individual samples.
PGC1a luciferase assay
Fibulin-4 þ/þ and Fibulin-4 R/R VSMCs were transiently transfected using lipofectamine 2000 (Invitrogen). Cells were dually transfected with PGC1a 2 kb firefly luciferase plasmid (Addgene plasmid 8887 30 ) and SV40-renilla luciferase plasmid (10:1). After 24 h, cells were washed with PBS, replenished with medium containing low serum (0.2% FCS) and cells were either treated overnight with TGFb1 (5 ng/mL, Biovision) to stimulate TGFb signalling, SB431542 hydrate (10 mM, Sigma), inhibitor of the TGFb receptor, Forskolin (10 mM, Sigma) for PGC1a activation, or DMSO as a negative control. After 24 h, cells were lysed and firefly/ renilla luciferase ratio was determined with the dual-luciferase assay system (Promega) using Glomax-multiþ detection (Promega) for each cell line. Relative luciferase levels were calculated by using the untreated Fibulin-4 þ/þ VSMCs (control) as reference value.
Statistical analysis
All experiments described were performed blinded by using cell line and mouse numbers without genotypes. Normal distribution of the data was assessed using the Shapiro Wilk test. The unpaired two-tailed Student's ttest was performed to analyse the specific sample groups for significant differences. All results are expressed as mean ± SEM. However, for data with non-normal distribution, log-transformation of the data, followed by the Student's t-test, was performed. A P-value <0.05 was considered to indicate a significant difference between groups. In the figures, P < 0.05 or P < 0.01 is shown with * and P < 0.001 with **. All analyses were performed using IBM SPSS Statistics version 21.0 (SPSS Inc., Chicago, IL, USA) or Graphpad.
Results
Proteomics analysis identifies increased mitochondrial protein levels in Fibulin-4 R/R aortas
For the proteomics analysis, protein extracts isolated from 3-month old thoracic aortas of Fibulin-4 R/R and Fibulin-4 þ/þ animals were used.
Reduction of Fibulin-4 protein was confirmed by western blot (Supplementary material online, Figure S1A , left panel). Proteome expression profiles were analysed using a 1D gradient gel of total aorta protein extract. Next, proteins separated on the gel were trypsin digested and identified by an MS/MS method coupled to Mascot database searches (Supplementary material online, Table S1 ). A duplicate analysis of the samples identified more than 75% of the proteins in the first analysis. Analysis of an independent set of aorta extracts identified more than 65% of the previously identified proteins. To determine differences in the proteome of Fibulin-4 R/R and Fibulin- Table S2 and Figure 1A ).
To verify this approach, we subsequently checked whether we could find proteins known to be associated with aneurysm formation based on three important associated factors: the ECM, TGFb, and RAS signalling. We used the AgBAse GOretriever for GO-term retrieval, which classifies proteins on the basis of cellular components (http://agbase.msstate.edu/cgibin/tools/goretriever_select.pl). Of the 374 proteins in total that were differentially expressed between Fibulin-4 R/R and wild-type mice, 342 GOterms could be assigned. Here, we observed that 14% of these proteins fell into the category 'ECM' ( Figure 1B) . Moreover, compared to wild-type, in the Fibulin-4 R/R aorta we observed over-representation of the ECM proteins elastin, fibrillin, fibronectin, laminin, and different collagen subtypes.
We performed confocal 3D imaging on aortic walls of Fibulin-4 þ/þ and Fibulin-4 R/R mice, showing expanded and disorganized elastin structure in the latter (Supplementary material online, Figure S1B ). In addition, western blot analysis showed increased amounts of elastin protein in Fibulin-4 Figure S1C ). Both results confirm the over-representation of the ECM proteins that we observed in proteomics data. Next to this overabundance of ECM proteins, 17% of the proteins fell into the category 'cytoskeleton'. Cytoskeleton proteins are closely connected to the ECM via integrins. Unexpectedly, we also observed that 17% of all proteins with significantly changed expression fell into the category 'mitochondria' ( Figure 1B) . Next, the 374 deregulated proteins were loaded into IPA for further analysis. Of these 374 protein IDs, 369 were mapped by IPA. We performed both a pathway and an upstream regulator analysis to get an idea of the changes in processes involved. TGFb1 itself turned out to be upregulated and was also predicted to be activated (based on 69 deregulated target molecules) as part of the upstream regulator analysis ( Figure 1C) . Thus, the proteomics data points to involvement of TGFb signalling in Fibulin-4 associated aneurysms as previously reported. 13, 22, 31 Both ACE as well as Rac1, which are part of the RAS pathway, were upregulated in the protein dataset of Fibulin-
angiotensinogen, a key molecule in the RAS pathway, was predicted to be upregulated ( Figure 1C) . Indeed, previous analysis of mouse aortas showed that angiotensinogen is increased in Fibulin-4 R/R animals com-
In conclusion, our proteome analysis reveals deregulation of TGFb signalling and RAS, processes already known to be changed in Fibulin-4 R/R aneurysms, validating our approach.
Canonical pathway analysis (IPA) pointed towards changes in cytoskeleton and integrin signalling ( Figure 1D) , as did the GO-analysis, which fits with Fibulin-4's functions within the ECM. Interestingly, mitochondrial dysfunction was also a significantly changed canonical pathway, which fits with the findings of the GO analysis showing a protein over-representation in the category 'mitochondria'. Taken together, next to factors known to be changed in aneurysm formation, our proteomics data analysis suggests changes in mitochondrial function in the aortas of Fibulin-4 R/R animals.
Decreased OCR in mutant Fibulin-4 and TGFb-1 receptor VSMCs
To investigate mitochondrial function, we analysed mitochondrial respiration using a Seahorse XF-24 Extracellular Flux Analyzer, which allows simultaneous measurement of the OCR and the ECAR. While OCR indicates respiration, ECAR reflects lactate production and thus glycolytic flux. OCR and ECAR thus provide a comprehensive estimate of the bioenergetics properties of the studied specimen. We observed a significantly decreased basal respiration (without addition of any inhibitor) in Fibulin-4 R/R VSMCs compared to Fibulin-4 þ/þ controls ( Figure 2A ,B, Phase I, P < 0.01). While no differences were observed in respiration after injection of the ATP synthase inhibitor oligomycin, the addition of FCCP, an oxidative phosphorylation (OXPHOS) uncoupler eliciting maximal respiration, indicated a significantly lower maximal OCR in Fibulin-4 R/R VSMCs (Figure 2A ,B, Phase III, P < 0.01). Complete repression of respiration by the combined addition of Complex I inhibitor rotenone and Complex III inhibitor antimycin A, led to the same OCR in Fibulin-4 R/R and Fibulin-4 þ/þ VSMCs, indicating that besides mitochondrial respiration, oxygen consumption differences due to other cellular processes are negligible (Figure 2A ). Experiments were repeated three times with two independent cell lines per genotype which gave similar consistent results ( Figure 2B) . Interestingly, ECAR was consistently higher in Fibulin- in aneurysms is not restricted to Fibulin-4 mutations per se but is present in VSMCs and fibroblasts of multiple thoracic aneurysmal aorta syndromes.
Complexes I, III, IV, and V levels and activity in Fibulin-4 R/R VSMCs and tissues
To investigate whether mitochondrial localization was affected by Fibulin-4 mutation, we first stained two independent Fibulin-4 R/R and Fibulin-4 þ/þ VSMC cell lines used in the Seahorse experiments with
Mitotracker CMX Ros and SiR-Actin. We observed no differences in mitochondrial localization or obvious differences in cytoskeletal composition between Fibulin-4 mutant or control cell lines ( Figure 3A) . We next performed fluorescence-activated cell sorting (FACS) experiments using VSMCs. In turn, this could indicate less mitochondrial complexes per cell, leading to decreases in OCR. However, the proteomics data showed a higher expression of mitochondrial complex proteins involved in OXPHOS. To investigate expression of mitochondrial complex proteins, we performed western blot analysis using thoracic aorta tissue with an antibody cocktail directed against five specific OXPHOS I-V complex subunits that are labile when its complex is not assembled. Interestingly, when compared to Fibulin-4 þ/þ , the protein level of Complexes I through IV was significantly (P < 0.05) increased in Fibulin-4 R/R aortas, whereas Complex V showed no significant change ( Figure   3D ,E). This is in agreement with the results from the proteomics analysis which showed that several individual mitochondrial complex proteins are upregulated. This could indicate a partial compensatory reaction of the respiratory electron transport chain (ETC) to counteract the decrease in mitochondrial mass. We also performed this western blot on Fibulin-4 SMKO aortic extracts and littermate controls, to see if deleting
Fibulin-4 in VSMCs alone could result in overexpression of these complexes. Indeed, we observed overexpression of Complexes I-IV in Fibulin-4 SMKO (Supplementary material online, Figure S1D ), however this was not a significant difference, indicating that other cells in the aorta of Fibulin-4 R/R animals may also contribute to this effect.
To see if decreased OCR is not limited to the aorta, we measured respiratory capacity in aorta, heart, muscle, and liver of Fibulin-4 þ/þ and Fibulin-4 R/R animals. Unfortunately, we were unable to determine OCR in aortic extracts, probably due to rigidity of the tissue because of ECM content. Nevertheless, heart and skeletal muscle, containing large amounts of muscle cells and highly dependent on mitochondrial activity, both showed a significantly lower OCR ( Figure 3F) . The liver did not show a lower, but somewhat higher (non-significant) OCR ( Figure 3F ), which we would expect if the observed OCR decrease is muscle cell specific. To determine whether the decreased oxygen consumption was due to reduced mitochondrial complex activity, we measured individual Complexes I, III, IV, and V activities (II is not subject to change), but observed no significant change ( Figure 3G) . These data fit with the observation that more Complexes I-IV proteins are present in the aorta ( Figure  3D,E) . Taken together, we can conclude that the reduced oxygen consumption is not due to lower complex activity.
Molecular imaging reveals increased ROS in the aorta of Fibulin-4 R/R animals
The observed imbalance between mitochondrial mass and the expression and activity of mitochondrial enzyme complexes may lead to an increase in generation of reactive oxygen species (ROS). In this context, we did observe a somewhat lower ADP ratio in Fibulin-4 R/R muscular tissues (data not shown), which would imply less efficient ATP production that could lead to more radical formation. To investigate if indeed more radicals are present, we performed molecular imaging using the L-012 probe. This probe emits a luminescent signal upon interaction with reactive oxygen and nitrogen species that is quantified using an IVIS spectrum imaging system. We 
Systemic metabolic analyses indicate a metabolic switch towards fatty acid oxidation in Fibulin-4 R/R animals
Previous gene expression studies performed on young Fibulin-4 R/R animals gave insight into the mechanism of aneurysm formation, amongst which were cytoskeleton re-organization and perturbed TGFb signalling. 13 As we observed many changes at the protein level pointing towards mitochondrial involvement, we wondered whether this would also be reflected at the transcriptional level. Additionally we were interested whether gene expression profiles could point to potential mechanisms and targets involved. Therefore, we performed gene expression analyses on 3-month old Fibulin-4 þ/þ and Fibulin-4 R/R thoracic aortas by using GeneChip mouse exon 1.0 ST arrays (Affymetrix). The obtained gene expression differences (P-value of 0.03; fold change 1.2) were uploaded and analysed in IPA. Canonical pathway analysis pointed towards numerous pathway changes related to metabolism (see Figure 5A for the top 10); out of the 30 canonical pathways predicted to be significantly changed (P < 0.01), 73% are directly involved in metabolic processes (data not shown). Moreover, when we examine the first 10 networks significantly changed based on our gene dataset, at the first position we find 'Energy Production/Lipid Metabolism/Small Molecule Biochemistry' (Supplementary material online, Figure S3 ).
To investigate if metabolic changes observed in the thoracic aorta are also reflected systemically in the mouse, we first analysed body weights of the mice. Indeed, Fibulin-4 R/R animals (n = 38) had a significantly lower body weight than Fibulin-4 þ/þ animals ( Figure 5B , P < 0.05). Next, we examined three important metabolic parameters: glucose, lactate, and ketones in blood of non-fasted Fibulin-4 þ/þ and Fibulin-4 R/R animals.
These parameters together shed light on the main metabolic processes used to generate ATP. Both blood glucose levels as well as blood lactate did not show significant differences between the two genotypes ( Figure  5C,D) . However, blood ketone levels were significantly lower in Fibulin-4 R/R compared to Fibulin-4 þ/þ animals ( Figure 5E , P < 0.01). Interestingly, in our gene expression analysis, we found that the key enzyme responsible for breakdown of ketones, is significantly upregulated in the aorta (3-oxoacid CoA transferase, OXCT1, 1.3-fold, P = 0.03, Supplementary material online, Figure S6A ). Figure S4B ). This could be due to absence or low expression of Fibulin-4 in the liver. Thus, based on the reduction of fatty acids in the liver together with reduction of ketones in the blood, it is likely that metabolism in the liver of Fibulin-4 R/R mice has shifted to fatty acid b-oxidation and the production of ketone bodies, to meet the altered demand in energy carrier type (ketone bodies vs. Figure S5A ), which may hint to processes that are important from an early time point on for aneurysm formation in these animals. Moreover, upstream regulator analysis predicted, amongst others, TGFB1, miR-29b, and PPARG to be significantly differentially regulated (Supplementary material online, Figure S5B) . Interestingly, TGFB1 and miR-29b have previously been published to be altered in Fibulin-4 R/R aortas, 13, 31, 32 and are here also found to be important key regulators. PPARG was not previously identified but plays an important role in fat metabolism. As we observed changes in fat and glycogen deposition in adult Fibulin-4 R/R livers compared to Fibulin-4
livers, we performed the same staining on newborn livers. However, we did not observe obvious changes in fat or glycogen deposition between Fibulin-4 R/R and Fibulin-4 þ/þ newborn livers (Supplementary material online, Figure S5C , n = 5 per genotype). These data together could indicate that the aneurysmal induced changes in metabolic processes may precede the metabolic changes in the liver.
Reduced PGC1a expression and activity in aortas and VSMCs of Fibulin-4 R/R animals
Since we discovered changes in mitochondrial function in thoracic aortas of Fibulin-4 R/R animals, it would be interesting to know which process or subset of factors is responsible. To investigate this, we looked at upstream regulators that are predicted to be significantly changed based on the gene expression data in the thoracic aorta of Fibulin-4 R/R animals.
Interestingly, PGC1a and PGC1b (peroxisome proliferator-activated receptor gamma, coactivator 1 a and b) as well as PPARa, PPARd and PPARc (peroxisome proliferator-activated receptor a, d, and c) were predicted to be significantly downregulated ( Table 2 ). In addition, we noticed that they were also all significantly downregulated at the gene expression level, except for PPARd, which showed no significant change ( Table 2) . Next, we performed real-time PCR analysis to check the mRNA expression levels of PGC1a, PGC1b, PPARa, and PPARc in thoracic aorta extracts of Fibulin-4 R/R and Fibulin-4 þ/þ animals. We found (Supplementary material online, Figure S4C ). Interestingly, in the liver we found that PGC1a was significantly upregulated (Supplementary material online, Figure S4D , P < 0.05), which would be consistent with the observed lower lipid content (higher lipid usage) of the liver ( Figure 5F ) and the somewhat higher OCR ( Figure 3G) . PGC1a is the master switch between mitochondrial biogenesis and organismal metabolism, and signals to PPARs, essential regulators of lipid metabolism, making these interesting molecules for further investigation. Moreover, when examining the networks predicted to be significantly regulated in our gene expression dataset, the highest significantly regulated network is 'Energy Production/Lipid Metabolism/Small Molecule Biochemistry' (Supplementary material online, Figure S3 ). The visual representation of this network, derived from IPA, highlights that PPARa and PPARc play a central role (Supplementary material online, Figure S6A) .
Next, we performed a gene to protein comparison, where we compared the lists of significantly regulated genes and proteins in adult Fibulin-4 R/R aortas to Fibulin-4 þ/þ . This comparison revealed 30 molecules that changed both at the gene and protein level (Supplementary material online, Figure S6B ). This list included key genes/proteins involved in metabolism, like glucose-6-phosphate dehydrogenase and fatty acid synthase (Supplementary material online, Figure S6B ). Strikingly, when we asked whether IPA could find a connection between the 30 overlapping molecules (core analysis on the 30 genes/proteins in common), we indeed found the highest network regulated to be Lipid Metabolism, in which again PPARa and PGC1a are involved as key regulators (Supplementary material online, Figure S6C ).
In order to check PGC1a activity in VSMCs, we used a luciferasebased assay. We transfected plasmids containing firefly luciferase under the control of the PGC1a promoter in Fibulin-4 R/R and Fibulin-4
VSMCs, with plasmids containing renilla luciferase as transfection control. Relative luciferase levels, a measure for PGC1a activity, were significantly lower in Fibulin-4 R/R VSMCs ( Figure 6B , P < 0.01). It was reported that TGFb signalling negatively regulates PGC1a. 33, 34 As we previously found TGFb signalling to be increased in Fibulin-4 R/R aortas and cells, 13, 31 we next investigated the effect of TGFb signalling on PGC1a. We performed the PGC1a luciferase-based assay on Fibulin-4 þ/þ and Fibulin- we either examined the effect of TGFbR inhibition, or PGC1a activation. Interestingly, activation of PGC1a increased basal and maximum oxygen consumption in both Fibulin-4 þ/þ and Fibulin-4 R/R VSMCs ( Figure 6D , P < 0.05), whereas TGFbR inhibition did not have the same effect. It was previously found that Fibulin-4 R/R VSMCs show low proliferation rates compared to Fibulin-4 þ/þ VSMCs, which can be rescued by inhibiting TGFb. 31 As TGFb negatively regulates PGC1a levels, we examined whether increased PGC1a levels would also rescue this low proliferation rate. Indeed, PGC1a activation was able to significantly increase the proliferation rate of Fibulin-4 R/R VSMCs specifically ( Figure 6E , P < 0.01).
Taken together, these results show that PGC1a, an important molecular switch between mitochondrial biogenesis and organismal metabolism, is downregulated in aortas of Fibulin-4 R/R animals due to increased TGFb 
Discussion
In this study, we took an integrative approach to better understand the molecular mechanisms involved in aneurysm formation, by using a com ) a connective tissue disorder characterized by elongation and tortuosity of the major arteries including the aorta. SLC2A10 encodes for GLUT10, a glucose transporter that transports l-dehydro ascorbic acid (DHA) into mitochondria. The absence of GLUT10 leads to decreased DHA recycling and thus to more oxidative damage. In zebrafish, defects in this gene lead to problems in development of the cardiovascular system in parallel to mitochondrial dysfunction. 36 In line with this notion, we demonstrate that
VSMCs from the Tgfbr-1 M318R/þ mouse, a model for LDS, 28 similarly show reduced OCR. Moreover, we find that Marfan and Loeys-Dietz patient fibroblasts with mutations in the FBN1, TGFBR2, and SMAD3 genes also show reduced OCR. These observations support the concept that altered mitochondrial function plays a role in aneurysmal disease. An important question is how a deficiency in a protein involved in structural integrity of the ECM can lead to altered mitochondrial function and metabolism. External cues can lead to cytoskeleton rearrangements since the ECM is connected to the cytoskeleton via integrins.
Alternatively, ECM disturbances could invoke alterations in mechanotransduction that lead to modifications in the cytoskeleton or maybe even to its disintegration. Mitochondria depend on the cytoskeleton for their motility and proper function (for review see reference 37 ). Thus, if the ECM disintegrates, this could lead to cytoskeleton disintegration due to loss of connections. In turn, this could lead to structural or functional defects in mitochondria. In fact, several genes that are components of the cytoskeleton are mutated in aneurysmal disease, exemplifying that the cytoskeleton is an important factor. One example is ACTA2, encoding aSMA, which is a major constituent of the contractile apparatus, that when mutated, leads to ascending aortic aneurysms and dissection (AAT6, OMIM##611788 38 ). However, although we did observe mitochondrial function changes and a reduction in mitochondrial size, mitochondrial structure and appearance did not seem to be affected. Also, mitochondria are still aligned along the actin cytoskeleton as could be inferred from EM pictures and stainings for actin.
In addition, Fibulin-4 R/R mice show increased TGFb signalling.
Notably, several papers recently reported that TGFb signalling negatively regulates PGC1a levels. 33, 34 Interestingly, derived from our omics data, PGC1a, PPARa, and c were identified as key components in the mitochondrial biogenesis signalling process. PGC1a is a transcriptional coactivator and is expressed in tissues with high oxidative capacity, where it serves important roles in regulation of mitochondrial functional capacity and cellular energy metabolism. 39 Physiological conditions that demand increased mitochondrial energy production, such as exercise and fasting, induce PGC1a activity. Likewise, low PGC1a levels imply reduced mitochondrial function. Accordingly, studies on PGC1a deficient (PGC1a -/-) mice have shown that PGC1a is necessary for regulation of mitochondrial function and cellular metabolism. 40 Both mitochondrial volume density and respiratory capacity are reduced in these mice and there is no normal control of body fat mass, which emphasizes the importance of PGC1a in fatty acid b-oxidation. Furthermore, PGC1a
-/-mice do not respond normally to increased demands for energy.
40
PGC1a is involved in the mitochondrial oxidation of fatty acids for energy in the cell through direct co-activation of PPARs. 39 Recently it was shown that PGC1a protein expression is also lowered in aortic material isolated from patients with abdominal aneurysms, 41 which indicates that PGC1a expression may play a regulatory role in both thoracic and abdominal aneurysms. 41 Moreover, increasing mitochondrial function via PGC1a activation has a positive effect on aging and longevity.
42,43
Interestingly, we not only found lower PGC1a expression in Fibulin-4 R/R thoracic aortas but also PGC1a transcriptional activation itself was down in Fibulin-4 R/R VSMCs. However, this activation could be enhanced by Forskolin, a PGC1a activator, and enhancement of PGC1a activation was able to restore the decreased oxidative respiration observed in Fibulin-4 R/R VSMCs.
We also found that TGFb decreased PGC1a transcriptional levels in Fibulin-4 þ/þ and Fibulin-4 R/R VSMCs, implying that the increased TGFb signalling in Fibulin-4 R/R aortas and VSMCs is responsible for the decreased PGC1a levels, thus impacting mitochondrial respiration. This Experiments were performed twice, n = 2 cell lines per genotype, the mean of two cell lines is shown. All results are expressed as mean ± SEM.
Reduced mitochondrial respiration in Fibulin-4 mice
